Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Professional Derma is a Swiss aesthetic medicine and skincare company that develops and commercializes the Jalupro line of injectable biorevitalizers, skincare, and related products. The company focuses on skin regeneration and rejuvenation using formulations that combine amino acids with hyaluronic acid, and in some products peptides, to support collagen production and tissue quality. Its products are marketed for anti-aging, wrinkle reduction, scar management, skin hydration, and periocular rejuvenation, with additional references to hair revitalization and applications beyond aesthetics. Professional Derma appears to operate primarily as a commercial-stage developer and marketer of medical devices and aesthetic products rather than as a traditional therapeutic drug developer. The company is headquartered in Lugano, Switzerland and presents itself as active internationally through the Jalupro brand.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Professional Derma.